FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
Status:
RECRUITING
Trial end date:
2030-07-31
Target enrollment:
Participant gender:
Summary
A multi-centre, prospective, blinded, randomised clinical trial of fludrocortisone compared with placebo in patients presenting with aneurysmal subarachnoid haemorrhage.
The study aim is to determine if early administration of enteral fludrocortisone in aneurysmal subarachnoid haemorrhage reduce death and dependency at six months.